This study used mouse models of HFD-induced obesity and confirmed the identification and unraveling of GPR41 for gut microbiota-produced HMPA from HMCA, which contributed to the anti-obesity effects and improved hepatic steatosis through evoked lipid catabolism pathway following the activation of the PKA–PPARα cascade. Here, FFAR3 is linked to fatty liver disease.